![Matthew Del Giudice](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Del Giudice
Directeur/Bestuurslid bij
MIRA PHARMACEUTICALS, INC.
Vermogen: - $ op 31-08-2026
Profiel
Dr. Matthew P.
Del Giudice, MD, is an Independent Director at Telomir Pharmaceuticals, Inc. and an Independent Director at MIRA Pharmaceuticals, Inc. He is on the Board of Directors at Telomir Pharmaceuticals, Inc. and MIRA Pharmaceuticals, Inc. Dr. Del Giudice was previously employed as a Head-General Overnight Emergency Radiologist by The Cleveland Clinic Foundation.
He received his undergraduate degree from the University of Illinois At Urbana–Champaign and a doctorate degree from Stritch School of Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 21-07-2026 | 0 ( -.--% ) | - $ | 31-08-2026 | |
| 21-07-2026 | 0 ( -.--% ) | - $ | 31-08-2026 |
Actieve functies van Matthew Del Giudice
| Bedrijven | Functie | Begin |
|---|---|---|
| MIRA PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 13-03-2024 |
| TELOMIR PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 12-08-2024 |
Eerdere bekende functies van Matthew Del Giudice
| Bedrijven | Functie | Einde |
|---|---|---|
The Cleveland Clinic Foundation
 The Cleveland Clinic Foundation Medical/Nursing ServicesHealth Services Provides healthcare services | Corporate Officer/Principal | 01-05-2022 |
Opleiding van Matthew Del Giudice
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
15
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
The Cleveland Clinic Foundation
The Cleveland Clinic Foundation Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Stritch School of Medicine
 Stritch School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois At Urbana–Champaign
 University of Illinois At Urbana–Champaign Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MIRA Pharmaceuticals, Inc.
 MIRA Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Develops and sells new molecular synthetic THC for the treatment of adult patients with anxiety and cognitive decline | Health Technology |
Telomir Pharmaceuticals, Inc.
 Telomir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops a novel small molecule as the first regulator of telomere length and genomic stability | Health Technology |
